11:30 am – 12:30 pm Friday, October 29

Joint Topic: Anticoagulation Therapy Anticoagulation Alphabet Soup: VKAs, LMWHs, and DOACs (214-1)

Treatment of thrombosis in pediatric patients presents many challenges. Thrombosis in pediatric patients has a wide range of etiologies, and researchers lack consensus about duration of therapy based on the thrombosis location and the presence of risk factors. Most patients under 18 years of age are treated with either parenteral low-molecular-weight heparins (LMWH) or vitamin K antagonists (VKAs).

Read more...
Speaker:
Ashleigh Brown, BSN RN CPN CPHON®
CNE Hours
1
RX Hours
0.25
11:30 am – 12:30 pm Saturday, October 30

Clinical Trials in the Children’s Oncology Group: A Case Study Approach (C229)

coglogoClinical trials are essential in the treatment of pediatric and young adult patients with cancer and have resulted in dramatic improvements in cure rates over the years. Because of clinical trials, we are now better able to understand the biology of different types of cancers affecting children and young adults and determine the best treatment options.

Read more...
3:30 – 4:30 pm Friday, October 29

Incorporating Children’s Oncology Group Health Links into Clinical Practice (C223)

coglogoThe care of children with cancer spans diagnosis and treatment, with the goal being survivorship. Approximately 80% of children diagnosed with cancer will survive, and many childhood cancer survivors may experience both physical and psychological late effects secondary to their cancer or its treatment.

Read more...
3:30 – 4:30 pm Friday, October 29

Hot Topics in Pediatric Oncology: Updates from the Children’s Oncology Group (C217)

coglogoImprovements in patient care occur when new research findings are moved into practice. The average length of time for this translation, however, is 17 years. Within the past 3 years, the Children’s Oncology Group (COG) has produced 248 publications (about 83 per year).

Read more...
5:00 – 6:00 pm Thursday, October 28

Lighting the Way in COG with MATCH: Targeted Therapies in Pediatric CNS Tumors (C211)

coglogoPediatric MATCH (Molecular Analysis for Therapy Choice) is a joint effort between the National Cancer Institute (NCI) and Children’s Oncology Group (COG) matching targeted therapies to specific tumor genomic sequencing in patients with relapsed or refractory solid tumors, non-Hodgkin lymphomas, brain tumors, and histiocytic disorders.

Read more...
11:30 am – 12:30 pm Saturday, October 30

Paper Presentation: Program Development — Building a Sustainable and Structured Continuing Education Program for Pediatric Oncology Nurses in Vietnam (228-3)

There is a lack of continuing education opportunities for oncology nurses at the 13 pediatric cancer treatment centers in Vietnam. This presentation will discuss how nurses from the United States, Singapore, and Vietnam collaborated to develop an in-country, web-based educational program utilizing a variety of virtual teaching strategies.

Read more...
11:30 am – 12:30 pm Saturday, October 30

Paper Presentation: Program Development — When Two Become One: Joining Two Programs to Promote Family-Centered Care for Pediatric Patients Undergoing Bone Marrow Transplantation (228-2)

Transplants often require families to be away from family and support networks for long periods of time. Patients are often acutely ill and require specialized care. Because of the complexity of treatment and the potential for complications, transplant is stressful and challenging for patients and their caregivers. To cope with this stress, many families rely on supportive systems, including family and friends.

Read more...
11:30 am – 12:30 pm Saturday, October 30

Paper Presentation: Program Development — Nursing Practice Advocate: An Innovative Role Created to Reduce Harm While Supporting and Engaging Bedside Nursing Staff (228-1)

In 2019, inpatient pediatric hematology/oncology (PHO) and stem cell transplant (SCT) units within a children’s hospital experienced an increase in central line–associated bloodstream infections (CLABSIs) and mucosal barrier injury laboratory-confirmed bloodstream infections (MBI-LCBIs).

Read more...

Pediatric Chemotherapy and Biotherapy Instructor Course (002)

The APHON Pediatric Chemotherapy and Biotherapy Instructor Course is designed for any nurse who has completed the provider course and meets the qualifications to be trained to teach the course. This course provides general instruction in adult education, guidance in the planning of lectures based on the APHON program content, and instruction in administering the provider exam. Upon successful completion, nurses return to their institutions as recognized APHON Pediatric Chemotherapy and Biotherapy Instructors who are able to provide ongoing instruction and education to other registered nurses.

Read more...

Translating Evidence into Practice: A Workshop Providing Mentorship, Collaboration, and Support to Assist in Implementation of EBP/QI Projects (006)

Evidence-based practice (EBP), quality improvement (QI), and research are fundamental to the nursing profession’s ability to remain relevant and up-to-date in an ever-changing and complex healthcare environment. The American Nurses Association (ANA) considers scholarly inquiry one of the essential features in the “advancement of professional nursing practice”.

Read more...
Speaker:

Danielle Gunter, PhD RN CPN

Lisa Bashore, PhD CPNP-PC CPON®

 

Fee
$110 for members
$140 for nonmembers
CNE Hours
3.25
Subscribe to this RSS feed